ALAMO GROUP INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ALAMO GROUP INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	845	912	1,009	1,119	1,163	1,334	1,514	1,690	1,629	1,604
Cost of revenue	640	678	753	846	870	1,000	1,137	1,236	1,216	1,206
Gross profit	205	235	256	273	294	335	377	454	412	398
Selling, general and administrative	137	143	152	173	184	203	213	240	231	230
Operating expenses							228	256	248	246
Operating income	67.6	88.7	101	94.9	94.8	117	149	198	165	152
Interest expense	5.91	4.84	5.49	10.7	15.8	10.5	14.4	26.1	20.5	14.9
Interest income	0.21	0.34	0.41	1.23	1.37	1.15	0.75	1.49	2.64	5.57
Other non-operating income	0.27	-1.87	-1.47	-0.8	-0.56	1.94	-0.67	1.76	2.73	-2.79
Pre-tax income	62.2	82.4	94.5	84.6	79.8	109	134	175	150	140
Income tax	22.1	38.1	21	21.5	22	29.3	32.4	39	33.7	35.7
Net income	40	44.3	73.5	63.1	57.8	80.2	102	136	116	104
EBITDA	78.9	100	114	110	114	138	172	222	192	179
EPS, basic	3.50	3.84	6.30	5.38	4.91	6.78	8.58	11.42	9.69	8.64
EPS, diluted	3.46	3.79	6.25	5.35	4.88	6.75	8.54	11.36	9.63	8.59
Shares, basic (weighted)	11.4	11.5	11.7	11.7	11.8	11.8	11.9	11.9	12	12
Shares, diluted (weighted)	11.6	11.7	11.8	11.8	11.8	11.9	11.9	12	12	12.1
Dividend per share	0.36	0.40	0.44	0.48	0.52	0.56	0.72	0.88	1.04	1.20

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	16.8	25.4	34	42.3	50.2	42.1	47	51.9	197	310
Receivables	170	206	228	238	209	238	318	362	306	277
Inventory	136	156	177	268	243	321	353	377	343	383
Other current assets	4.73	5.34	5.33	10.1	7.38	9.5	9.14	12.5	11.2	11.6
Total current assets	328	393	453	571	516	612	727	804	857	998
Property, plant and equipment	66.6	76.7	87.2	161	155	152	155	167	158	166
Lease right-of-use assets				12.9	14.1	16.7	17.2	16.3	18.1	14.2
Goodwill	74.8	84.8	83.2	198	195	202	196	207	203	215
Intangible assets	50	52.9	48.9	206	193	183	171	168	151	145
Other non-current assets	2.08	3.36	3.7	19.4	19.1	21.6	24.4	23.3	26	20.6
Total assets	553	640	722	1,213	1,122	1,206	1,309	1,409	1,450	1,607
Accounts payable	43.1	55.8	54.1	82	75.3	101	97.5	99.7	84.5	125
Accrued liabilities	33.2	40.5	43.8	59.7	64.6	73.5	71.4	86.7	77.5	75.9
Deferred revenue		0.2	2.52	2.43	1.39	6.38	5.2	6.22	8.56	3.19
Short-term debt	0.07	0.08	0.12	18.8	15	15	15	15	15	15
Total current liabilities	78.7	101	101	163	157	193	191	214	190	218
Long-term debt	70	60	85	425	270	255	287	220	205	191
Lease liabilities				8.99	10.6	12.2	12.8	11.3	11.8	8.4
Other non-current liabilities	6.97	7.29	8.44	19.3	32.5	27.1	23.7	23.7	24.6	24.1
Total liabilities	165	191	206	635	487	500	523	477	432	458
Total debt	70.1	60.1	85.1	18.8	15	15	15	15	220	206
Paid-in capital	99.8	104	108	114	119	124	130	138	147	155
Retained earnings	335	375	443	500	560	634	727	853	956	1,046
Treasury stock	-0.43	-0.43	-0.43	-4.57	-4.57	-4.57	-4.57	-4.57	-4.57	-4.57
Other comprehensive income	-47.8	-30.2	-44.8	-40.8	-40.3	-49	-68.3	-54.5	-81.6	-49.1
Shareholders' equity	388	449	515	578	635	706	785	933	1,018	1,149
Total equity	388	449	515	578	635	706	785	933	1,018	1,149
Total liabilities and equity	553	640	722	1,213	1,122	1,206	1,309	1,409	1,450	1,607
Shares outstanding	11.5	11.6	11.7	11.8	11.8	11.9	11.9	12	12	12.1

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	40	44.3	73.5	63.1	57.8	80.2	102	136	116	104
Depreciation and amortization	11.3	11.6	12.9	14.9	19.3	21.2	23.7	23.7	26.9	27.1
Stock-based compensation	1.41	1.87	2.45	3.27	4.12	5.99	5.56	7.42	9.14	9.94
Deferred income tax	2.62	1.33	2.05	3.38	-0.86	-1.18	-2.34	-4.25	-3.61	10.6
Change in receivables	3.88	-23.1	-27	11.4	28.1	-27.6	-85.1	-35.3	47	40.6
Change in inventory	12.3	0.14	-26	0.39	38.3	-78.5	-37.7	-10.8	26.5	-28.1
Change in payables	-5.38	11.7	4.13	6.4	-3.78	32.5	-2.88	4.81	-15.7	30.2
Cash from operations	75.8	70.8	12.9	88.8	184	49.7	14.5	131	210	178
Capital expenditures	-9.71	-13.5	-26.6	-31.3	-17.9	-25.3	-31.1	-37.7	-25	-30.6
Acquisitions	-0.19	-38.6	0	-401	0	-17.8	-2	-27.6	0	-18.3
Cash from investing	-8.66	-51.3	-25.4	-430	-14.2	-33.4	-31.7	-52.6	-22.2	-46.2
Debt issued	0.05	0	0	300	0	0
Stock issued	1.37	2.4	2.55	2.57	1.46	1.68	0.8	1.59	1.91	1.65
Share buybacks	-0.02	-0.17	-0.44	-0.59	-0.71	-1.96	-0.77	-1.03	-1.97	-3.02
Dividends paid	-4.11	-4.61	-5.12	-5.63	-6.12	-6.63	-8.55	-10.5	-12.4	-14.4
Cash from financing	-77.3	-12.4	22.2	349	-164	-23	24.5	-76.9	-32	-30.8
Exchange rate effect	0.09	1.45	-1.09	0.17	1.96	-1.31	-2.35	3.25	-10.3	11.8
Net change in cash	-10.1	8.58	8.67	8.27	7.88	-8.08	4.9	4.9	145	112
Free cash flow	66.1	57.3	-13.7	57.5	166	24.4	-16.6	93.4	185	147
Interest paid	5.8	5.22	5.2	9.46	17	10.2	14.6	25.4	20.8	14.7
Income taxes paid	16.6	23.2	30.3	23.1	17.1	32.9	35.1	37.3	40.4	52.9

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $159.45 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	24.2%	Gross profit / revenue.
Operating margin	8.9%	Operating income / revenue.
EBITDA margin	10.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	8.2%	Pre-tax income / revenue.
Net margin	6.1%	Net income / revenue.
FCF margin	8.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	9.8%	Cash from operations / revenue.
Effective tax rate	26.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	8.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	5.9%	Net income / average total assets.
Return on invested capital (ROIC)	8.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	14.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.7%	Capital expenditures / revenue.
D&A / revenue	1.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-1.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	1.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	6.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-3.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	1.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	6.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-8.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	0.7%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	9.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-6.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	1.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	9.4%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-10.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	0.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	12.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-10.8%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	0.2%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	12.0%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-15.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	130.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-0.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-20.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-2.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	15.4%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	18.6%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	18.2%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	12.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	13.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	12.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	10.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	7.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	7.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	4.39x	Current assets / current liabilities.
Quick ratio	2.38x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.86x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.22x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	15.2%	Total debt / total assets.
Liabilities / assets	31.1%	Total liabilities / total assets.
Net debt	$67.7M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.39x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	8.50x	Operating income / interest expense.
Working capital	$766.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	28.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	$703.8M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.96x	Revenue / average total assets.
Fixed asset turnover	10.3x	Revenue / average property, plant and equipment.
Inventory turnover	2.91x	Cost of revenue / average inventory.
Days inventory	125 days	365 x average inventory / cost of revenue.
Receivables turnover	4.84x	Revenue / average receivables.
Days sales outstanding	75 days	365 x average receivables / revenue.
Days payables	43 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	158 days	Days inventory + days sales outstanding - days payables.
FCF conversion	133.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	17.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$8.33	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$137.07	Revenue / diluted weighted shares.
FCF per share	$11.16	Free cash flow / diluted weighted shares.
Operating cash flow per share	$13.47	Cash from operations / diluted weighted shares.
Book value per share	$98.12	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$58.12	Tangible book value / shares outstanding.
Cash per share	$16.10	(Cash + short-term investments) / shares outstanding.
Payout ratio	15.3%	Dividends paid / net income, when net income is positive.
Dividends / FCF	11.4%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	9.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.94B	Share price x shares outstanding.
Enterprise value	$2.01B	Market cap + total debt - cash - short-term investments.
P/E	19.2x	Market cap / net income. Only when net income is positive.
P/S	1.17x	Market cap / revenue.
P/B	1.63x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.76x	Market cap / tangible book value, when positive.
P/FCF	14.3x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	11.9x	Market cap / cash from operations, when positive.
EV/Sales	1.21x	Enterprise value / revenue.
EV/EBIT	13.6x	Enterprise value / operating income, when both are positive.
EV/EBITDA	11.5x	Enterprise value / EBITDA, when both are positive.
EV/FCF	14.8x	Enterprise value / free cash flow, when both are positive.
FCF yield	7.0%	Free cash flow / market cap.
Earnings yield	5.2%	Net income / market cap (the inverse of P/E).
Dividend yield	0.8%	Dividends paid over the period / market cap.
Shareholder yield	1.4%	(Dividends paid + share buybacks) / market cap.
PEG	98.6x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was ALAMO GROUP INC's revenue in fiscal 2025?

ALAMO GROUP INC reported revenue of $1.60B for fiscal 2025, 1.5% lower than the year before.

Was ALAMO GROUP INC profitable in fiscal 2025?

Yes. Net income was $103.8M, a net margin of 6.5%.

How much free cash flow did ALAMO GROUP INC generate in fiscal 2025?

Cash from operations of $177.5M minus capital expenditures of $30.6M left free cash flow of $146.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ALAMO GROUP INC